Abstract
Ochronosis commonly affects all connective tissue. Recognition of changes secondary to the deposition of ochronotic pigments has increased with advances in diagnostic technology, allowing both improved imaging and early biochemical and genetics-based diagnosis of alkaptonuria, the cause of ochronosis. Successful symptomatic treatment of ochronotic arthropathy with joint replacement has been documented, and a new pharmacotherapeutic agent, nitisinone, is currently under investigation for both prevention and treatment of ochronosis. This review of the literature highlights recently recognized complications, new diagnostic techniques, and treatment options.
Similar content being viewed by others
References
Selvi E, Manganelli S, Benucci M, Marcolongo R (2000) Chronic ochronotic arthritis: clinical, arthroscopic and pathologic findings. J Rheumatol 27:2272–4
Sahin G, Milcan A, Bagis S, Kokturk A, Pata C, Erdogan C (2001) A case of ochronosis: upper extremity involvement. Rheumatol Int 21:78–80
Kumar RV, Rajasekaran S (2003) Spontaneous tendon ruptures in alkaptonuria. J Bone Joint Surg Br 85:883–6
Farzannia A, Shokouhi G, Hadidchi S (2003) Alkaptonuria and lumbar disc herniation. J Neurosurg (Spine 1) 98:87–9
Hamdi N, Cooke TDV, Hassan B (1999) Ochronotic arthropathy: case report and review of the literature. Int Orthop 23:122–5
Laskar FH, Sargison KD (1970) Ochronotic arthropathy: a review with four case reports. J Bone Joint Surg Br 52:653–65
Ellaway CJ, Holme E, Standing S, Preece MA, Green A, Ploechl E et al (2001) Outcome of tyrosinemia type III. J Inher Metab Dis 24:824–32
La Du B (2002) Alkaptonuria. In: Royce RM, Steinman B (eds) Connective tissue and its heritable disorders: molecular, genetic and medical aspects. Second edn. Wiley-Liss, New York, pp 809–825
Aydogdu S, Cullu E, Ozsoy MH, Sur H (2000) Cementless total knee arthroplasty in ochronotic arthropathy: a case report with 4-year follow-up. J Arthroplasty 15:539–43
Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphey MD, Fitzpatrick DL et al (2002) Natural history of alkaptonuria. N Engl J Med 347:2111–21
Nas K, Gur A, Akdeniz S, Cevik R, Harman M, Sarac AJ (2002) Ochronosis: a case of severe ochronotic arthropathy. Clin Rheumatol 21:170–2
Alrehaily A, Pope JE (2002) Alkaptonuria with atypical joint involvement. J Rheumatol 29:198–9
MacKenzie CR, Major P, Hunter T (1982) Tendon involvement in a case of ochronosis. J Rheumatol 9:634–6
Seradge H (1981) Ochronotic stenosing flexor tenosynovitis. J Hand Surg 6:359–60
Uyguner O, Goicoechea de Jorge E, Cefle A, Baykal T, Kayserili H, Cefle K, Demirkol M, Yuksel-Apak M, Rodriguez de Cordoba S, Wollnik B (2003) Molecular analyses of the HGO gene mutations in Turkish alkaptonuria patients suggest that the R58 fs mutation originated from central Asia and was spread throughout Europe and Anatolia by human migrations. J Inherit Metab Dis 26:17–23
Zatkova A, Chmelikova A, Polakova H, Ferakova E, Kadasi L (2003) Rapid detection methods for five HGO gene mutations causing alkaptonuria. Clin Genet 63:145–9
Aliberti G, Pulignano I, Schiappoli A, Minisola S, Romagnoli E, Proietta M (2003) Bone metabolism in ochronotic patients. J Int Med 254:296–300
Borman P, Bodur H, Ciliz D (2002) Ochronotic arthropathy. Rheumatol Int 21:205–9
Carrier DA, Harris CM (1990) Bilateral hip and bilateral knee arthroplasties in a patient with ochronotic arthropathy. Orthop Rev 19:1005–9
Suzuki Y, Oda K, Yoshikawa Y, Maeda T, Suzuki T (1999) A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria. J Hum Genet 44:79–84
Lock EA, Ellis MK, Gaskin P, Robinson M, Auton TR, Provan WM et al (1998) From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTMC), its toxicology and development as a drug. J Inher Metab Dis 21:498–506
Beighton P (1993) Alkaptonuria. McKusick’s heritable disorders of connective tissue. Fourth edn. Mosby, St. Louis, pp 315–30
Author information
Authors and Affiliations
Corresponding author
Additional information
No grants or industrial support were received for this investigation
Rights and permissions
About this article
Cite this article
Keller, J.M., Macaulay, W., Nercessian, O.A. et al. New developments in ochronosis: review of the literature. Rheumatol Int 25, 81–85 (2005). https://doi.org/10.1007/s00296-004-0498-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-004-0498-1